Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Clinical trial NCT03229096 · UNKNOWN
Trial details
- NCT number
- NCT03229096
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2021-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.